Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6902)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Atreya R, Billmeier U, Rath T, Mudter J, Vieth M, Neumann H, Neurath MF. First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy. World J Gastroenterol 2015; 21(45): 12963-12969 [PMID: 26668517 DOI: 10.3748/wjg.v21.i45.12963] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i45/12963.htm |
| Number | Citing Articles |
| 1 |
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseases. World Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
|
| 2 |
Andrew N. Wilkinson, Karshing Chang, Rachel D. Kuns, Andrea S. Henden, Simone A. Minnie, Kathleen S. Ensbey, Andrew D. Clouston, Ping Zhang, Motoko Koyama, Juan Hidalgo, Stefan Rose-John, Antiopi Varelias, Slavica Vuckovic, Kate H. Gartlan, Geoffrey R. Hill. IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling. Blood 2019; 134(23): 2092 doi: 10.1182/blood.2019000396
|
| 3 |
Yusuke Hanioka, Katsushu Shimizu, Keiko Yamagami, Shuhei Yao, Ryota Nakamura, Tomoyuki Nakamura, Hitoshi Goto. Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis. Internal Medicine 2021; 60(10): 1615 doi: 10.2169/internalmedicine.5215-20
|
| 4 |
|
| 5 |
Rachele Del Sordo, Vassilios Lougaris, Gabrio Bassotti, Alessandro Armuzzi, Vincenzo Villanacci. Therapeutic agents affecting the immune system and drug-induced inflammatory bowel disease (IBD): A review on etiological and pathogenetic aspects. Clinical Immunology 2022; 234: 108916 doi: 10.1016/j.clim.2021.108916
|
| 6 |
D. E. Elliott, J. V. Weinstock. Nematodes and human therapeutic trials for inflammatory disease. Parasite Immunology 2017; 39(5) doi: 10.1111/pim.12407
|
| 7 |
Akiko Shibata, Takahiko Kurasawa, Yusuke Okada, Kentaro Chino, Shuntaro Saito, Ayumi Okuyama, Hirofumi Takei, Ryota Sakai, Tsuneo Kondo, Koichi Amano. Successful treatment with tocilizumab monotherapy for Takayasu arteritis developing during infliximab therapy in a patient with ulcerative colitis. Modern Rheumatology Case Reports 2018; 2(2): 174 doi: 10.1080/24725625.2018.1479155
|
| 8 |
Sebastian Zundler, Markus Neurath. Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer. Vaccines 2016; 4(1): 5 doi: 10.3390/vaccines4010005
|
| 9 |
Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi. Effectiveness of tocilizumab in Behcet's disease: A systematic literature review. Seminars in Arthritis and Rheumatism 2020; 50(4): 797 doi: 10.1016/j.semarthrit.2020.05.017
|
| 10 |
Matthew Chak Hin Szeto, Metin Devrim Yalçın, Abdul Khan, Andrzej Piotrowicz. Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis. Case Reports in Immunology 2016; 2016: 1 doi: 10.1155/2016/7562123
|
| 11 |
K Aden, A Breuer, A Rehman, H Geese, F Tran, J Sommer, G H Waetzig, T M Reinheimer, S Schreiber, S Rose-John, J Scheller, P Rosenstiel. Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair. Oncogenesis 2016; 5(11): e270 doi: 10.1038/oncsis.2016.71
|
| 12 |
Carolina L. Bellera, Mauricio E. Di Ianni, Alan Talevi. The application of molecular topology for ulcerative colitis drug discovery. Expert Opinion on Drug Discovery 2018; 13(1): 89 doi: 10.1080/17460441.2018.1396314
|
| 13 |
Raffaele Borghini, Mariavittoria Vescovo, Carla Giordano, Giuseppe Donato, Antonio Picarelli. Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis. Inflammatory Bowel Diseases 2021; 27(6): e76 doi: 10.1093/ibd/izab036
|
| 14 |
Abhinandan Devaprasad, Timothy R. D. J. Radstake, Aridaman Pandit. Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.669400
|
| 15 |
Rosa Camacho-Sandoval, Eréndira N. Sosa-Grande, Edith González-González, Alejandra Tenorio-Calvo, Carlos A. López-Morales, Marco Velasco-Velázquez, Lenin Pavón-Romero, Sonia Mayra Pérez-Tapia, Emilio Medina-Rivero. Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection. Journal of Pharmaceutical and Biomedical Analysis 2018; 155: 235 doi: 10.1016/j.jpba.2018.03.057
|
| 16 |
Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi. Does microbiome contribute to HLA-B52-positive Takayasu arteritis?. Modern Rheumatology 2020; 30(1): 213 doi: 10.1080/14397595.2019.1584146
|
| 17 |
Claudia A. Collier, Steven Foncerrada, Abigail J. Clevenger, Ashok Shetty, Shreya A. Raghavan. Acute Exposure to Pyridostigmine Bromide Disrupts Cholinergic Myenteric Neuroimmune Function in Mice. Advanced Biology 2023; 7(5) doi: 10.1002/adbi.202200254
|
| 18 |
Vera Buchele, Patrick Konein, Tina Vogler, Timo Kunert, Karin Enderle, Hanif Khan, Maike Büttner-Herold, Christian H. K. Lehmann, Lukas Amon, Stefan Wirtz, Diana Dudziak, Markus F. Neurath, Clemens Neufert, Kai Hildner. Th17 Cell-Mediated Colitis Is Positively Regulated by Interferon Regulatory Factor 4 in a T Cell-Extrinsic Manner. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.590893
|
| 19 |
Stefan Schreiber, Konrad Aden, Joana P. Bernardes, Claudio Conrad, Florian Tran, Hanna Höper, Valery Volk, Neha Mishra, Johanna Ira Blase, Susanna Nikolaus, Johannes Bethge, Tanja Kühbacher, Christoph Röcken, Minhu Chen, Ian Cottingham, Niclas Petri, Birgitte B. Rasmussen, Juliane Lokau, Lennart Lenk, Christoph Garbers, Friedrich Feuerhake, Stefan Rose-John, Georg H. Waetzig, Philip Rosenstiel. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease. Gastroenterology 2021; 160(7): 2354 doi: 10.1053/j.gastro.2021.02.062
|
| 20 |
Naoimh Herlihy, Roger Feakins. Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?. United European Gastroenterology Journal 2022; 10(5): 451 doi: 10.1002/ueg2.12242
|
| 21 |
Holm H. Uhlig, Fiona Powrie. Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease. Annual Review of Immunology 2018; 36(1): 755 doi: 10.1146/annurev-immunol-042617-053055
|
| 22 |
Shadi Hamdeh, Dejan Micic, Stephen Hanauer. Drug-Induced Colitis. Clinical Gastroenterology and Hepatology 2021; 19(9): 1759 doi: 10.1016/j.cgh.2020.04.069
|